Merrimack Pharmaceuticals Inc (OQ:MACK)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for MACK within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 21st, 2022
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 20/22 Jan 18/22 Crocker Gary L Indirect Ownership Common Stock P - Open market or private purchase 5,000 $4.54
Jan 18/22 Jan 14/22 Crocker Gary L Indirect Ownership Common Stock P - Open market or private purchase 5,000 $4.51
Jan 18/22 Jan 13/22 Crocker Gary L Indirect Ownership Common Stock P - Open market or private purchase 5,000 $4.42
Jan 13/22 Jan 12/22 Crocker Gary L Indirect Ownership Common Stock P - Open market or private purchase 5,000 $4.33
Jan 13/22 Jan 11/22 Crocker Gary L Indirect Ownership Common Stock P - Open market or private purchase 5,000 $4.03
Jan 12/22 Jan 11/22 Levy Noah G. Indirect Ownership Common Stock P - Open market or private purchase 14,728 $4.00
Jan 12/22 Jan 11/22 Levy Noah G. Indirect Ownership Common Stock P - Open market or private purchase 76,542 $4.00
Jan 12/22 Jan 10/22 Levy Noah G. Indirect Ownership Common Stock P - Open market or private purchase 5,960 $3.83
Jan 12/22 Jan 10/22 Levy Noah G. Indirect Ownership Common Stock P - Open market or private purchase 8,719 $3.83
Jan 10/22 Jan 7/22 Levy Noah G. Indirect Ownership Common Stock P - Open market or private purchase 3,565 $3.82
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for MACK within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 21st, 2022
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 20/22 Jan 18/22 Crocker Gary L Indirect Ownership Common Stock P - Open market or private purchase 5,000 $4.54
Jan 18/22 Jan 14/22 Crocker Gary L Indirect Ownership Common Stock P - Open market or private purchase 5,000 $4.51
Jan 18/22 Jan 13/22 Crocker Gary L Indirect Ownership Common Stock P - Open market or private purchase 5,000 $4.42
Jan 13/22 Jan 12/22 Crocker Gary L Indirect Ownership Common Stock P - Open market or private purchase 5,000 $4.33
Jan 13/22 Jan 11/22 Crocker Gary L Indirect Ownership Common Stock P - Open market or private purchase 5,000 $4.03
Jan 12/22 Jan 11/22 Levy Noah G. Indirect Ownership Common Stock P - Open market or private purchase 14,728 $4.00
Jan 12/22 Jan 11/22 Levy Noah G. Indirect Ownership Common Stock P - Open market or private purchase 76,542 $4.00
Jan 12/22 Jan 10/22 Levy Noah G. Indirect Ownership Common Stock P - Open market or private purchase 5,960 $3.83
Jan 12/22 Jan 10/22 Levy Noah G. Indirect Ownership Common Stock P - Open market or private purchase 8,719 $3.83
Jan 10/22 Jan 7/22 Levy Noah G. Indirect Ownership Common Stock P - Open market or private purchase 3,565 $3.82
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $MACK

Competitors

Competitors with Recent Insider Filings
Moderna (OQ:MRNA)
Iqvia Holdings (N:IQV)
Medpace Holdings (OQ:MEDP)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.